Artykuły w czasopismach na temat „Cerebral ischemia – Treatment”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Cerebral ischemia – Treatment”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Kanazawa, Masato, Tetsuya Takahashi, Masanori Ishikawa, Osamu Onodera, Takayoshi Shimohata i Gregory J. del Zoppo. "Angiogenesis in the ischemic core: A potential treatment target?" Journal of Cerebral Blood Flow & Metabolism 39, nr 5 (6.03.2019): 753–69. http://dx.doi.org/10.1177/0271678x19834158.
Pełny tekst źródłaSiesjö, Bo K. "Pathophysiology and treatment of focal cerebral ischemia". Journal of Neurosurgery 77, nr 3 (wrzesień 1992): 337–54. http://dx.doi.org/10.3171/jns.1992.77.3.0337.
Pełny tekst źródłaWang, Lei, Xu Zhang, Xiaoxing Xiong, Hua Zhu, Ran Chen, Shudi Zhang, Gang Chen i Zhihong Jian. "Nrf2 Regulates Oxidative Stress and Its Role in Cerebral Ischemic Stroke". Antioxidants 11, nr 12 (30.11.2022): 2377. http://dx.doi.org/10.3390/antiox11122377.
Pełny tekst źródłaSiesjö, Bo K. "Pathophysiology and treatment of focal cerebral ischemia". Journal of Neurosurgery 108, nr 3 (marzec 2008): 616–31. http://dx.doi.org/10.3171/jns/2008/108/3/0616.
Pełny tekst źródłaSiesjö, Bo K. "Pathophysiology and treatment of focal cerebral ischemia". Journal of Neurosurgery 77, nr 2 (sierpień 1992): 169–84. http://dx.doi.org/10.3171/jns.1992.77.2.0169.
Pełny tekst źródłaHan, Xue Mei, Hong Tao Wei i Song Yan Liu. "Involvement of Erythropoietin Expression in Acupuncture Preconditioning-Induced Ischemic Tolerance". Advanced Materials Research 554-556 (lipiec 2012): 1650–55. http://dx.doi.org/10.4028/www.scientific.net/amr.554-556.1650.
Pełny tekst źródłaSong, Siying, Hao Wu, Xunming Ji i Ran Meng. "The BE COOL Treatments (Batroxobin, oxygEn, Conditioning, and cOOLing): Emerging Adjunct Therapies for Ischemic Cerebrovascular Disease". Journal of Clinical Medicine 11, nr 20 (20.10.2022): 6193. http://dx.doi.org/10.3390/jcm11206193.
Pełny tekst źródłaSpetzler, Robert F. "Treatment of chronic cerebral ischemia". Surgical Neurology 23, nr 2 (luty 1985): 201. http://dx.doi.org/10.1016/0090-3019(85)90350-7.
Pełny tekst źródłaGhosh, Nilanjan, Rituparna Ghosh, Zulfiqar A. Bhat, Vivekananda Mandal, Sitesh C. Bachar, Namsa D. Nima, Otimenyin O. Sunday i Subhash C. Mandal. "Advances in Herbal Medicine for Treatment of Ischemic Brain Injury". Natural Product Communications 9, nr 7 (lipiec 2014): 1934578X1400900. http://dx.doi.org/10.1177/1934578x1400900739.
Pełny tekst źródłaHan, Xue Mei, Hong Tao Wei i Song Yan Liu. "Functional Role of HIF-1α in Hypoxic Preconditioning-Induced Neuroprotection against Focal Cerebral Ischemia". Advanced Materials Research 554-556 (lipiec 2012): 1762–67. http://dx.doi.org/10.4028/www.scientific.net/amr.554-556.1762.
Pełny tekst źródłaDong, Chao, Jiawei Li, Ming Zhao, Lin Chen, Xiaochen Zhai, Lingling Song, Jin Zhao, Qiang Sun, Jie Wu i Xiaolu Xie. "Pharmacological Effect of Panax notoginseng Saponins on Cerebral Ischemia in Animal Models". BioMed Research International 2022 (4.08.2022): 1–12. http://dx.doi.org/10.1155/2022/4281483.
Pełny tekst źródłaYe, Hui, Zaiming Liu, Long Zhou i Qiang Cai. "Dynamic Observation of the Effect of L-Theanine on Cerebral Ischemia-Reperfusion Injury Using Magnetic Resonance Imaging under Mathematical Model Analysis". Journal of Healthcare Engineering 2021 (26.10.2021): 1–7. http://dx.doi.org/10.1155/2021/5679665.
Pełny tekst źródłaLopez, Mary S., Robert J. Dempsey i Raghu Vemuganti. "Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles". Journal of Cerebral Blood Flow & Metabolism 36, nr 9 (21.07.2016): 1644–50. http://dx.doi.org/10.1177/0271678x16656202.
Pełny tekst źródłaLi, Jin-hui, Jing Lu i Hong Zhang. "Functional Recovery after Scutellarin Treatment in Transient Cerebral Ischemic Rats: A Pilot Study with18F-Fluorodeoxyglucose MicroPET". Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/507091.
Pełny tekst źródłaYano, Toshiyuki, Sakiko Anraku, Ryosuke Nakayama i Kazuo Ushijima. "Neuroprotective Effect of Urinary Trypsin Inhibitor against Focal Cerebral Ischemia–Reperfusion Injury in Rats". Anesthesiology 98, nr 2 (1.02.2003): 465–73. http://dx.doi.org/10.1097/00000542-200302000-00028.
Pełny tekst źródłaYagita, Yoshiki, Kazuo Kitagawa, Naoki Oyama, Toshiro Yukami, Akihiro Watanabe, Tsutomu Sasaki i Hideki Mochizuki. "Functional Deterioration of Endothelial Nitric Oxide Synthase after Focal Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 33, nr 10 (3.07.2013): 1532–39. http://dx.doi.org/10.1038/jcbfm.2013.112.
Pełny tekst źródłaPikis, Stylianos, Georgios Mantziaris, Vasileios Mamalis, Konstantinos Barkas, Antonios Tsanis, Stavroula Lyra, Kuriakos Karkoulias, Tigran Petrosyan i Eftychios Archontakis. "Diffusion weighted image documented cerebral ischemia in the postprocedural period following pipeline embolization device with shield technology treatment of unruptured intracranial aneurysms: a prospective, single center study". Journal of NeuroInterventional Surgery 12, nr 4 (26.09.2019): 407–11. http://dx.doi.org/10.1136/neurintsurg-2019-015363.
Pełny tekst źródłaYu, Yong-Qiang, Lian-Cheng Liu, Fa-Cai Wang, Yan Liang, Da-Qin Cha, Jing-Jing Zhang, Yu-Jun Shen, Hai-Ping Wang, Shengyun Fang i Yu-Xian Shen. "Induction Profile of MANF/ARMET by Cerebral Ischemia and its Implication for Neuron Protection". Journal of Cerebral Blood Flow & Metabolism 30, nr 1 (23.09.2009): 79–91. http://dx.doi.org/10.1038/jcbfm.2009.181.
Pełny tekst źródłaSavić, Tanja, Giuseppe Gambino, Vahid S. Bokharaie, Hamid R. Noori, Nikos K. Logothetis i Goran Angelovski. "Early detection and monitoring of cerebral ischemia using calcium-responsive MRI probes". Proceedings of the National Academy of Sciences 116, nr 41 (23.09.2019): 20666–71. http://dx.doi.org/10.1073/pnas.1908503116.
Pełny tekst źródłaAhad, Mohamad Anuar, Kesevan Rajah Kumaran, Tiang Ning, Nur Izzati Mansor, Mohamad Azmeer Effendy, Thenmoly Damodaran, Kamilla Lingam i in. "Insights into the neuropathology of cerebral ischemia and its mechanisms". Reviews in the Neurosciences 31, nr 5 (28.07.2020): 521–38. http://dx.doi.org/10.1515/revneuro-2019-0099.
Pełny tekst źródłaJacewicz, Michael, Steve Brint, Jody Tanabe, Xing-Je Wang i William A. Pulsinelli. "Nimodipine Pretreatment Improves Cerebral Blood Flow and Reduces Brain Edema in Conscious Rats Subjected to Focal Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 10, nr 6 (listopad 1990): 903–13. http://dx.doi.org/10.1038/jcbfm.1990.147.
Pełny tekst źródłaJacewicz, Michael, Steve Brint, Jody Tanabe i William A. Pulsinelli. "Continuous Nimodipine Treatment Attenuates Cortical Infarction in Rats Subjected to 24 Hours of Focal Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 10, nr 1 (styczeń 1990): 89–96. http://dx.doi.org/10.1038/jcbfm.1990.11.
Pełny tekst źródłaSun, Jui-Ming, Ting-Lin Yen, Jing-Shiun Jan, Pharaoh Fellow Mwale, Ruei-Dun Teng, Rajeev Taliyan, Cheng-Ta Hsieh i Chih-Hao Yang. "Advances in Antibody-Based Therapeutics for Cerebral Ischemia". Pharmaceutics 15, nr 1 (31.12.2022): 145. http://dx.doi.org/10.3390/pharmaceutics15010145.
Pełny tekst źródłaVongsfak, Jirapong, Wasana Pratchayasakul, Nattayaporn Apaijai, Tanat Vaniyapong, Nipon Chattipakorn i Siriporn C. Chattipakorn. "The Alterations in Mitochondrial Dynamics Following Cerebral Ischemia/Reperfusion Injury". Antioxidants 10, nr 9 (30.08.2021): 1384. http://dx.doi.org/10.3390/antiox10091384.
Pełny tekst źródłaPackard, Amy E. B., Jason C. Hedges, Frances R. Bahjat, Susan L. Stevens, Michael J. Conlin, Andres M. Salazar i Mary P. Stenzel-Poore. "Poly-IC Preconditioning Protects against Cerebral and Renal Ischemia-Reperfusion Injury". Journal of Cerebral Blood Flow & Metabolism 32, nr 2 (16.11.2011): 242–47. http://dx.doi.org/10.1038/jcbfm.2011.160.
Pełny tekst źródłaSmirnov, Ivan E., A. A. Stepanov, L. D. Shakina, I. A. Belyaeva, E. P. Bombardirova i A. G. Kucherenko. "Neurologic manifestations of cerebral ischemia in infants at 1 year of age". Russian Pediatric Journal 19, nr 5 (30.04.2019): 274–82. http://dx.doi.org/10.18821/1560-9561-2016-19-5-274-282.
Pełny tekst źródłaZhang, Chan, Luming Zhen, Zongping Fang, Liang Yu, Yuanyuan Zhang, Haidong Wei, Junfeng Jia i Shiquan Wang. "Adiponectin Treatment Attenuates Cerebral Ischemia-Reperfusion Injury through HIF-1α-Mediated Antioxidation in Mice". Oxidative Medicine and Cellular Longevity 2021 (14.07.2021): 1–16. http://dx.doi.org/10.1155/2021/5531048.
Pełny tekst źródłaMarteau, Léna, Samuel Valable, Didier Divoux, Simon A. Roussel, Omar Touzani, Eric T. MacKenzie, Myriam Bernaudin i Edwige Petit. "Angiopoietin-2 is Vasoprotective in the Acute Phase of Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 33, nr 3 (5.12.2012): 389–95. http://dx.doi.org/10.1038/jcbfm.2012.178.
Pełny tekst źródłaArmstrong, SL. "Cerebral vasospasm: early detection and intervention". Critical Care Nurse 14, nr 4 (1.08.1994): 33–37. http://dx.doi.org/10.4037/ccn1994.14.4.33.
Pełny tekst źródłaDu, Fang, Tao Tang, Qingzhu Li i Jiaxin Liu. "Fyn Signaling in Ischemia-Reperfusion Injury: Potential and Therapeutic Implications". Mediators of Inflammation 2022 (15.09.2022): 1–10. http://dx.doi.org/10.1155/2022/9112127.
Pełny tekst źródłaLim, Songhyun, Tae Jung Kim, Young-Ju Kim, Cheesue Kim, Sang-Bae Ko i Byung-Soo Kim. "Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury". International Journal of Molecular Sciences 22, nr 21 (4.11.2021): 11967. http://dx.doi.org/10.3390/ijms222111967.
Pełny tekst źródłaPu, Fengling, Kenichi Mishima, Nobuaki Egashira, Yuki Akiyoshi, An-Xin Liu, Kazunori Sano, Keiichi Irie i in. "Post-ischemic Treatment with Toki-Shakuyaku-San (Tang-Gui-Shao-Yao-San) Prevents the Impairment of Spatial Memory Induced by Repeated Cerebral Ischemia in Rats". American Journal of Chinese Medicine 33, nr 03 (styczeń 2005): 475–89. http://dx.doi.org/10.1142/s0192415x05003077.
Pełny tekst źródłaGodínez-Rubí, Marisol, Argelia E. Rojas-Mayorquín i Daniel Ortuño-Sahagún. "Nitric Oxide Donors as Neuroprotective Agents after an Ischemic Stroke-Related Inflammatory Reaction". Oxidative Medicine and Cellular Longevity 2013 (2013): 1–16. http://dx.doi.org/10.1155/2013/297357.
Pełny tekst źródłaLiang, Jia, Zhifeng Qi, Wenlan Liu, Peng Wang, Wenjuan Shi, Wen Dong, Xunming Ji, Yumin Luo i Ke Jian Liu. "Normobaric Hyperoxia Slows Blood–Brain Barrier Damage and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in Cerebral Ischemia". Stroke 46, nr 5 (maj 2015): 1344–51. http://dx.doi.org/10.1161/strokeaha.114.008599.
Pełny tekst źródłaLu, Hongwei, Yaqin Meng, Xinrui Han i Wei Zhang. "ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury". Journal of Healthcare Engineering 2021 (16.12.2021): 1–14. http://dx.doi.org/10.1155/2021/3097432.
Pełny tekst źródłaBullock, R., D. I. Graham, S. Swanson i J. McCulloch. "Neuroprotective Effect of the AMPA Receptor Antagonist LY-293558 in Focal Cerebral Ischemia in the Cat". Journal of Cerebral Blood Flow & Metabolism 14, nr 3 (maj 1994): 466–71. http://dx.doi.org/10.1038/jcbfm.1994.57.
Pełny tekst źródłaFan, Yan-Ying, Zhe Shen, Ping He, Lei Jiang, Wei-wei Hou, Yao Shen, Xiang-Nan Zhang, Wei-Wei Hu i Zhong Chen. "A Novel Neuroprotective Strategy for Ischemic Stroke: Transient Mild Acidosis Treatment by CO2 Inhalation at Reperfusion". Journal of Cerebral Blood Flow & Metabolism 34, nr 2 (6.11.2013): 275–83. http://dx.doi.org/10.1038/jcbfm.2013.193.
Pełny tekst źródłaRegli, Luca, Mark C. Held, Robert E. Anderson i Fredric B. Meyer. "Nitric Oxide Synthase Inhibition by L-NAME Prevents Brain Acidosis during Focal Cerebral Ischemia in Rabbits". Journal of Cerebral Blood Flow & Metabolism 16, nr 5 (wrzesień 1996): 988–95. http://dx.doi.org/10.1097/00004647-199609000-00024.
Pełny tekst źródłaSchulz, Mette K., Lars Peter Wang, Mogens Tange i Per Bjerre. "Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage". Journal of Neurosurgery 93, nr 5 (listopad 2000): 808–14. http://dx.doi.org/10.3171/jns.2000.93.5.0808.
Pełny tekst źródłaSchweizer, Sophie, Andreas Meisel i Stefanie Märschenz. "Epigenetic Mechanisms in Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 33, nr 9 (12.06.2013): 1335–46. http://dx.doi.org/10.1038/jcbfm.2013.93.
Pełny tekst źródłaIwata, Naohiro, Hiroko Takayama, Meiyan Xuan, Shinya Kamiuchi, Hirokazu Matsuzaki, Mari Okazaki i Yasuhide Hibino. "Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats". BioMed Research International 2015 (2015): 1–10. http://dx.doi.org/10.1155/2015/189292.
Pełny tekst źródłaZakharov, V. V., V. V. Grinyuk, N. V. Vakhnina i E. Yu Kalimeeva. "Treatment of comorbid patients with chronic brain ischemia and vertebrogenic pain syndromes". Medical Council, nr 9 (12.06.2019): 15–20. http://dx.doi.org/10.21518/2079-701x-2019-9-15-20.
Pełny tekst źródłaISHIKAWA, Tatsuya. "Advancement in Treatment for Ischemic Cerebral Ischemia in the Acute Stage". Surgery for Cerebral Stroke 33, nr 2 (2005): 85–88. http://dx.doi.org/10.2335/scs.33.85.
Pełny tekst źródłaKoerner, Ines P., Matthias Gatting, Ruediger Noppens, Oliver Kempski i Ansgar M. Brambrink. "Induction of Cerebral Ischemic Tolerance by Erythromycin Preconditioning Reprograms the Transcriptional Response to Ischemia and Suppresses Inflammation". Anesthesiology 106, nr 3 (1.03.2007): 538–47. http://dx.doi.org/10.1097/00000542-200703000-00019.
Pełny tekst źródłaMeng, Wei, Xiaoying Wang, Minoru Asahi, Tsuneo Kano, Kazuko Asahi, Robert H. Ackerman i Eng H. Lo. "Effects of Tissue Type Plasminogen Activator in Embolic versus Mechanical Models of Focal Cerebral Ischemia in Rats". Journal of Cerebral Blood Flow & Metabolism 19, nr 12 (grudzień 1999): 1316–21. http://dx.doi.org/10.1097/00004647-199912000-00004.
Pełny tekst źródłaChen, Jun, Roger P. Simon, Tesuya Nagayama, Raymond Zhu, J. Eric Loeffert, Simon C. Watkins i Steven H. Graham. "Suppression of Endogenous bcl-2 Expression by Antisense Treatment Exacerbates Ischemic Neuronal Death". Journal of Cerebral Blood Flow & Metabolism 20, nr 7 (lipiec 2000): 1033–39. http://dx.doi.org/10.1097/00004647-200007000-00002.
Pełny tekst źródłaCaraban, B. M., Aurelia Romila, L. T. Hangan i Mihaela Lungu. "Cerebral Vasospasm in Subarachnoid Hemorrhage Through Aneurysm Rupture - Clinical Considerations and Case Report". ARS Medica Tomitana 22, nr 4 (1.11.2016): 232–38. http://dx.doi.org/10.1515/arsm-2016-0040.
Pełny tekst źródłaSharma, Shyam S., Shankar Munusamy, Meenakshisundaram Thiyagarajan i Chaman L. Kaul. "Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate—ribose) polymerase inhibitor alone and in combination in rats with focal ischemia". Journal of Neurosurgery 101, nr 4 (październik 2004): 669–75. http://dx.doi.org/10.3171/jns.2004.101.4.0669.
Pełny tekst źródłaFedin, A. I. "Diagnosis and treatment of chronic cerebral ischemia". Consilium Medicum 18, nr 2 (2016): 8–12. http://dx.doi.org/10.26442/2075-1753_2016.2.8-12.
Pełny tekst źródłaZakharov, V. V., N. V. Vakhnina, A. G. Gogoleva i S. K. Mezhmidinova. "Diagnostics and treatment of chronic cerebral ischemia". Meditsinskiy sovet = Medical Council, nr 8 (16.07.2020): 36–45. http://dx.doi.org/10.21518/2079-701x-2020-8-36-45.
Pełny tekst źródła